Dr. Xiao Zhang, PharmD, is a clinician, scientist and product commercialization leader whose entrepreneurial drive and marketing acumen are transforming the pharmaceutical industry.
Zhang serves as the head of global pipeline commercialization and strategy for gastroenterology at AbbVie, where she leads the vision and execution for bringing the next generation of medicines to patients suffering from gastrointestinal diseases. In her role, she is responsible for shaping the long-term strategy for AbbVie’s gastroenterology pipeline—identifying future market opportunities, defining value drivers and ensuring that new medicines address the greatest patient needs. Zhang leads cross-functional teams spanning commercial, medical, discovery, clinical development and market access to create and execute comprehensive asset plans from early discovery to commercial decision. She and the global pipeline commercialization and strategy organization assess new investment opportunities and play a key role in redefining the treatment paradigm for inflammatory bowel disease, helping AbbVie maintain its leadership in immunology and gastroenterology.
Zhang has a Doctor of Pharmacy degree from Rutgers University and a Master of Business Administration from Northwestern University Kellogg School of Management. Her success stems from her breadth of experience, passion for customers and patients and inspiration from her colleagues. Recognized for passion, vision and a collaborative spirit, Zhang is not only shaping the future of medicine but also serving as a role model for the next generation of healthcare leaders.